Annual Accounts Payable
$113.80 K
-$41.70 K-26.82%
December 31, 2023
Summary
- As of February 26, 2025, PTIX annual accounts payable is $113.80 thousand, with the most recent change of -$41.70 thousand (-26.82%) on December 31, 2023.
- During the last 3 years, PTIX annual accounts payable has fallen by -$28.10 thousand (-19.80%).
- PTIX annual accounts payable is now -99.27% below its all-time high of $15.57 million, reached on June 30, 2013.
Performance
PTIX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$108.60 K
+$15.10 K+16.15%
September 30, 2024
Summary
- As of February 26, 2025, PTIX quarterly accounts payable is $108.60 thousand, with the most recent change of +$15.10 thousand (+16.15%) on September 30, 2024.
- Over the past year, PTIX quarterly accounts payable has increased by +$15.10 thousand (+16.15%).
- PTIX quarterly accounts payable is now -98.99% below its all-time high of $10.76 million, reached on March 31, 2008.
Performance
PTIX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PTIX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.8% | +16.1% |
| 3 y3 years | -19.8% | +16.1% |
| 5 y5 years | +1038.0% | +16.1% |
PTIX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.2% | at low | -67.5% | +16.1% |
| 5 y | 5-year | -59.2% | at low | -67.5% | +71.0% |
| alltime | all time | -99.3% | +5590.0% | -99.0% | +5330.0% |
Protagenic Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $108.60 K(+16.1%) |
| Jun 2024 | - | $93.50 K(-14.2%) |
| Mar 2024 | - | $109.00 K(-4.2%) |
| Dec 2023 | $113.80 K(-26.8%) | $113.80 K(-53.3%) |
| Sep 2023 | - | $243.50 K(+53.9%) |
| Jun 2023 | - | $158.20 K(-9.5%) |
| Mar 2023 | - | $174.90 K(+12.5%) |
| Dec 2022 | $155.50 K(-44.3%) | $155.50 K(+11.6%) |
| Sep 2022 | - | $139.30 K(-58.3%) |
| Jun 2022 | - | $334.30 K(+19.7%) |
| Mar 2022 | - | $279.30 K(+0.1%) |
| Dec 2021 | $279.00 K(+96.6%) | $279.00 K(+2.0%) |
| Sep 2021 | - | $273.60 K(+48.1%) |
| Jun 2021 | - | $184.70 K(-21.0%) |
| Mar 2021 | - | $233.70 K(+64.7%) |
| Dec 2020 | $141.90 K(-12.9%) | $141.90 K(+29.4%) |
| Sep 2020 | - | $109.70 K(+30.3%) |
| Jun 2020 | - | $84.20 K(+32.6%) |
| Mar 2020 | - | $63.50 K(-61.0%) |
| Dec 2019 | $163.00 K(+1530.0%) | $163.00 K(+151.2%) |
| Sep 2019 | - | $64.90 K(+13.9%) |
| Jun 2019 | - | $57.00 K(+21.8%) |
| Mar 2019 | - | $46.80 K(+368.0%) |
| Dec 2018 | $10.00 K(-9.1%) | $10.00 K(-75.8%) |
| Sep 2018 | - | $41.30 K(-65.0%) |
| Jun 2018 | - | $118.10 K(+973.6%) |
| Dec 2017 | $11.00 K(-17.9%) | $11.00 K(-17.9%) |
| Dec 2016 | $13.40 K(-92.0%) | $13.40 K(-36.5%) |
| Sep 2016 | - | $21.10 K(+111.0%) |
| Jun 2016 | - | $10.00 K(-80.7%) |
| Mar 2016 | - | $51.70 K(-73.1%) |
| Dec 2015 | - | $192.00 K(+10.3%) |
| Sep 2015 | - | $174.00 K(+3.6%) |
| Jun 2015 | $168.00 K(+21.7%) | $168.00 K(-2.3%) |
| Mar 2015 | - | $172.00 K(+4.9%) |
| Dec 2014 | - | $164.00 K(0.0%) |
| Sep 2014 | - | $164.00 K(+18.8%) |
| Jun 2014 | $138.00 K(-99.1%) | $138.00 K |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | $15.57 M(+248.2%) | - |
| Sep 2011 | - | $5.23 M(+87.7%) |
| Jun 2011 | - | $2.79 M(-13.5%) |
| Mar 2011 | - | $3.22 M(-27.9%) |
| Dec 2010 | $4.47 M(-28.6%) | $4.47 M(+4.8%) |
| Sep 2010 | - | $4.26 M(-5.7%) |
| Jun 2010 | - | $4.52 M(-10.9%) |
| Mar 2010 | - | $5.07 M(-18.9%) |
| Dec 2009 | $6.26 M(-13.0%) | $6.26 M(-10.0%) |
| Sep 2009 | - | $6.96 M(-0.7%) |
| Jun 2009 | - | $7.01 M(-33.9%) |
| Mar 2009 | - | $10.60 M(+47.3%) |
| Dec 2008 | $7.19 M(+120.9%) | $7.19 M(-10.0%) |
| Sep 2008 | - | $7.99 M(+84.9%) |
| Jun 2008 | - | $4.32 M(-59.8%) |
| Mar 2008 | - | $10.76 M(+230.5%) |
| Dec 2007 | $3.26 M(+13.5%) | $3.26 M(-39.9%) |
| Sep 2007 | - | $5.42 M(+152.3%) |
| Jun 2007 | - | $2.15 M(-9.4%) |
| Mar 2007 | - | $2.37 M(+8245.1%) |
| Dec 2006 | $2.87 M(>+9900.0%) | - |
| Oct 2006 | - | $28.40 K(+1320.0%) |
| Jul 2006 | - | $2000.00(-16.7%) |
| Jul 2006 | $2000.00(-96.0%) | - |
| Apr 2006 | - | $2400.00(-88.1%) |
| Jan 2006 | - | $20.10 K(-59.6%) |
| Oct 2005 | - | $49.70 K(-98.3%) |
| Jul 2005 | $50.00 K(-97.8%) | - |
| Oct 1999 | - | $3.00 M(-3.2%) |
| Apr 1999 | - | $3.10 M(-35.4%) |
| Jan 1999 | - | $4.80 M(+41.2%) |
| Oct 1998 | - | $3.40 M(+41.7%) |
| Apr 1998 | - | $2.40 M(-33.3%) |
| Jan 1998 | - | $3.60 M(+56.5%) |
| Oct 1997 | - | $2.30 M(0.0%) |
| Jul 1997 | $2.30 M | $2.30 M(-20.7%) |
| Apr 1997 | - | $2.90 M(+61.1%) |
| Jan 1997 | - | $1.80 M |
FAQ
- What is Protagenic Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual accounts payable year-on-year change?
- What is Protagenic Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly accounts payable year-on-year change?
What is Protagenic Therapeutics annual accounts payable?
The current annual accounts payable of PTIX is $113.80 K
What is the all time high annual accounts payable for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual accounts payable is $15.57 M
What is Protagenic Therapeutics annual accounts payable year-on-year change?
Over the past year, PTIX annual accounts payable has changed by -$41.70 K (-26.82%)
What is Protagenic Therapeutics quarterly accounts payable?
The current quarterly accounts payable of PTIX is $108.60 K
What is the all time high quarterly accounts payable for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly accounts payable is $10.76 M
What is Protagenic Therapeutics quarterly accounts payable year-on-year change?
Over the past year, PTIX quarterly accounts payable has changed by +$15.10 K (+16.15%)